UNI EN ISO 29701 : 2010
Current
The latest, up-to-date edition.
NANOTECHNOLOGIES - ENDOTOXIN TEST ON NANOMATERIAL SAMPLES FOR IN VITRO SYSTEMS - LIMULUS AMEBOCYTE LYSATE (LAL) TEST
06-09-2011
PREMESSA
INTRODUZIONE
1 SCOPO E CAMPO DI APPLICAZIONE
2 TERMINI E DEFINIZIONI
3 ABBREVIAZIONI
4 CONSIDERAZIONI PRIMA DELLA PROVA
5 CAMPIONE DI PROVA
6 PREPARAZIONE DEL CAMPIONE DI PROVA
7 METODI DI PROVA
8 VALUTAZIONE DEI RISULTATI
9 RESOCONTO DI PROVA
APPENDICE A (informativa) - ESEMPI DI INTERFERENZE POTENZIALI
SULLA PROVA LAL
APPENDICE B (informativa) - METODO DEL COAGULO GEL
APPENDICE C (informativa) - METODO FOTOMETRICO DI ENDPOINT
APPENDICE D (informativa) - METODO CINETICO
BIBLIOGRAFIA
Explains the application of a test using Limulus amebocyte lysate (LAL) reagent for the evaluation of nanomaterials intended for cell-based in vitro biological test systems.
Committee |
CT 29
|
DevelopmentNote |
Bilingual (Italian + English) version issued in SEPTEMBER 2011. (09/2011)
|
DocumentType |
Standard
|
PublisherName |
Ente Nazionale Italiano di Unificazione (UNI)
|
Status |
Current
|
ISO 14644-2:2015 | Cleanrooms and associated controlled environments Part 2: Monitoring to provide evidence of cleanroom performance related to air cleanliness by particle concentration |
ISO 10993-12:2012 | Biological evaluation of medical devices Part 12: Sample preparation and reference materials |
ISO 14644-7:2004 | Cleanrooms and associated controlled environments — Part 7: Separative devices (clean air hoods, gloveboxes, isolators and mini-environments) |
ISO 14644-1:2015 | Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness by particle concentration |
ISO/TS 80004-1:2015 | Nanotechnologies — Vocabulary — Part 1: Core terms |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.